Tg(Camk2a-Ppp3ca*)CN98Kndl
Transgene Detail
|
|
| Symbol: |
Tg(Camk2a-Ppp3ca*)CN98Kndl |
| Name: |
transgene insertion CN98, Eric R Kandel |
| MGI ID: |
MGI:3809256 |
| Synonyms: |
DeltaCaM-AI |
| Transgene: |
Tg(Camk2a-Ppp3ca*)CN98Kndl Location: unknown
|
| Alliance: |
Tg(Camk2a-Ppp3ca*)CN98Kndl page
|
|
| Strain of Origin: |
(C57BL/6J x CBA/J)F2
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(Camk2a-Ppp3ca*)CN98Kndl expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Note |
| mouse |
Ppp3ca (MGI:107164) |
|
|
| |
|
Mutation details: A cDNA encoding a truncated and active form of the murine calcineurin catlytic subunit, CaM-AI, which lacks the autoinhibitory domain and a portion of the calmodulin binding domain of calcineurin, was placed under the control of the mouse Camk2a promoter.
(J:77291)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:77291 Winder DG, et al., Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell. 1998 Jan 9;92(1):25-37 |
| All: |
7 reference(s) |
|